$ACHC
Acadia Healthcare Company, Inc.

2023 Q3 Form 10-Q Financial Statement

#000095017023035484 Filed on July 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $750.3M $731.3M
YoY Change 12.54% 12.22%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $478.6M $468.3M
YoY Change 11.34% 12.56%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $33.40M $32.01M
YoY Change 12.94% 9.9%
% of Gross Profit
Operating Expenses $616.0M $596.2M
YoY Change 12.32% 12.47%
Operating Profit
YoY Change
Interest Expense -$20.70M -$20.91M
YoY Change 14.98% 26.23%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$287.4M $96.43M
YoY Change -395.98% -12.06%
Income Tax -$71.87M $22.88M
% Of Pretax Income 23.73%
Net Earnings -$217.7M $72.30M
YoY Change -406.21% -9.72%
Net Earnings / Revenue -29.02% 9.89%
Basic Earnings Per Share -$2.39 $0.79
Diluted Earnings Per Share -$2.39 $0.79
COMMON SHARES
Basic Shares Outstanding 92.17M 92.03M
Diluted Shares Outstanding 91.17M 91.55M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $99.60M $112.2M
YoY Change 6.62% -12.62%
Cash & Equivalents $99.59M $112.2M
Short-Term Investments
Other Short-Term Assets $241.2M $61.76M
YoY Change 114.92% -30.88%
Inventory $5.475M $5.437M
Prepaid Expenses $38.08M $26.88M
Receivables $362.7M $345.8M
Other Receivables $14.29M $53.55M
Total Short-Term Assets $703.5M $578.8M
YoY Change 34.85% 11.72%
LONG-TERM ASSETS
Property, Plant & Equipment $2.146B $2.202B
YoY Change 4.94% 18.54%
Goodwill $2.226B $2.223B
YoY Change 0.82% 0.79%
Intangibles $73.81M $71.61M
YoY Change -2.78% 1.98%
Long-Term Investments
YoY Change
Other Assets $72.43M $75.38M
YoY Change -22.11% -17.42%
Total Long-Term Assets $4.643B $4.571B
YoY Change 5.01% 4.74%
TOTAL ASSETS
Total Short-Term Assets $703.5M $578.8M
Total Long-Term Assets $4.643B $4.571B
Total Assets $5.346B $5.150B
YoY Change 8.16% 5.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $149.9M $148.9M
YoY Change 29.15% 33.56%
Accrued Expenses $620.4M $208.2M
YoY Change 135.25% -7.66%
Deferred Revenue $2.585M $4.052M
YoY Change -72.76%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $26.56M $24.90M
YoY Change 25.0% 17.16%
Total Short-Term Liabilities $864.9M $432.5M
YoY Change 115.68% -2.08%
LONG-TERM LIABILITIES
Long-Term Debt $1.350B $1.372B
YoY Change -2.13% -0.85%
Other Long-Term Liabilities $145.9M $240.9M
YoY Change -38.28% 106.01%
Total Long-Term Liabilities $1.496B $1.613B
YoY Change -7.42% 7.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $864.9M $432.5M
Total Long-Term Liabilities $1.496B $1.613B
Total Liabilities $2.536B $2.229B
YoY Change 15.31% 3.97%
SHAREHOLDERS EQUITY
Retained Earnings $73.99M $291.7M
YoY Change -19.8% 1278.23%
Common Stock $2.639B $2.629B
YoY Change -0.49% -0.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.713B $2.921B
YoY Change
Total Liabilities & Shareholders Equity $5.346B $5.150B
YoY Change 8.16% 5.48%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$217.7M $72.30M
YoY Change -406.21% -9.72%
Depreciation, Depletion And Amortization $33.40M $32.01M
YoY Change 12.94% 9.9%
Cash From Operating Activities $137.8M $163.8M
YoY Change 235.8% 9.76%
INVESTING ACTIVITIES
Capital Expenditures $128.0M $90.83M
YoY Change -267.65% -210.89%
Acquisitions
YoY Change
Other Investing Activities -$1.300M $66.00K
YoY Change -22.43% -101.58%
Cash From Investing Activities -$129.4M -$90.77M
YoY Change 65.85% 5.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -21.00M -24.66M
YoY Change -1129.92% -67.17%
NET CHANGE
Cash From Operating Activities 137.8M 163.8M
Cash From Investing Activities -129.4M -90.77M
Cash From Financing Activities -21.00M -24.66M
Net Change In Cash -12.60M 48.34M
YoY Change -63.95% -502.9%
FREE CASH FLOW
Cash From Operating Activities $137.8M $163.8M
Capital Expenditures $128.0M $90.83M
Free Cash Flow $9.800M $72.94M
YoY Change -91.65% -68.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001520697
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35331
dei Entity Registrant Name
EntityRegistrantName
Acadia Healthcare Company, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2492228
dei Entity Address Address Line1
EntityAddressAddressLine1
6100 Tower Circle
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1000
dei Entity Address City Or Town
EntityAddressCityOrTown
Franklin
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37067
dei City Area Code
CityAreaCode
615
dei Local Phone Number
LocalPhoneNumber
861-6000
dei Security12b Title
Security12bTitle
Common Stock, $.01 par value
dei Trading Symbol
TradingSymbol
ACHC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
92171758
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112173000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
97649000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
345836000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
322439000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
120748000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
86037000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
578757000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
506125000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2074142000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1952045000
CY2023Q2 us-gaap Goodwill
Goodwill
2222805000
CY2022Q4 us-gaap Goodwill
Goodwill
2222805000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
71607000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
76041000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2885000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2950000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
127515000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
135238000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72497000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92697000
CY2023Q2 us-gaap Assets
Assets
5150208000
CY2022Q4 us-gaap Assets
Assets
4987901000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
23906000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
21250000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
148896000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
104723000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
111409000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
125298000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26422000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26463000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
121849000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
110592000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
432482000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
388326000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1372362000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1364541000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
92870000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
92588000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
110869000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
116429000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
130026000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
125033000
CY2023Q2 us-gaap Liabilities
Liabilities
2138609000
CY2022Q4 us-gaap Liabilities
Liabilities
2086917000
CY2023Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
90583000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
88257000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91128740
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91128740
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89913659
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89913659
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
911000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
899000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2628403000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2658440000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
291702000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
153388000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2812727000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5150208000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4987901000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
731337000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
651719000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1435604000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1268372000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7348000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6580000
us-gaap Share Based Compensation
ShareBasedCompensation
14977000
us-gaap Share Based Compensation
ShareBasedCompensation
14505000
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
386633000
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
339388000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
777810000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
675150000
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
43803000
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
40440000
us-gaap Professional Fees
ProfessionalFees
84928000
us-gaap Professional Fees
ProfessionalFees
77351000
CY2023Q2 us-gaap Supplies Expense
SuppliesExpense
26144000
CY2022Q2 us-gaap Supplies Expense
SuppliesExpense
25022000
us-gaap Supplies Expense
SuppliesExpense
52165000
us-gaap Supplies Expense
SuppliesExpense
48721000
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
11725000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
11192000
us-gaap Operating Lease Expense
OperatingLeaseExpense
23149000
us-gaap Operating Lease Expense
OperatingLeaseExpense
22441000
CY2023Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
95912000
CY2022Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
84937000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
186750000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
166362000
CY2022Q2 achc Income From Provider Relief Fund
IncomeFromProviderReliefFund
8550000
achc Income From Provider Relief Fund
IncomeFromProviderReliefFund
8550000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
32012000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
29128000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
63581000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
58054000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-20910000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-16565000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-40909000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-32352000
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
8694000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
8694000
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9074000
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3940000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
15545000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7522000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
634907000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
542062000
us-gaap Costs And Expenses
CostsAndExpenses
1253531000
us-gaap Costs And Expenses
CostsAndExpenses
1079403000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
96430000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
109657000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
182073000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
188969000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22881000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27725000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41966000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45127000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
73549000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
81932000
us-gaap Profit Loss
ProfitLoss
140107000
us-gaap Profit Loss
ProfitLoss
143842000
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1250000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1853000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1793000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2926000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
72299000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
80079000
us-gaap Net Income Loss
NetIncomeLoss
138314000
us-gaap Net Income Loss
NetIncomeLoss
140916000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.57
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.54
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91044000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89724000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90691000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89492000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91546000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91473000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91640000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91504000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2517489000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3749000
CY2022Q1 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-15490000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7925000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
60837000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2574510000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3148000
CY2022Q2 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-1275000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6580000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
80079000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2663042000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3067000
CY2022Q3 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-740000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7240000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
71099000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2743708000
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1649000
CY2022Q4 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-287000
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7890000
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1357000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
61124000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2812727000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1203000
CY2023Q1 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-48874000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7629000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
902000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
66015000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2839602000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3784000
CY2023Q2 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-2017000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7348000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
72299000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2921016000
us-gaap Profit Loss
ProfitLoss
140107000
us-gaap Profit Loss
ProfitLoss
143842000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
63581000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
58054000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1651000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1620000
us-gaap Share Based Compensation
ShareBasedCompensation
14977000
us-gaap Share Based Compensation
ShareBasedCompensation
14505000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
347000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7975000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
8694000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1086000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-396000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23397000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19763000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
8743000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
18106000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
322000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2550000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21518000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25518000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-13889000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2682000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
2568000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
7928000
achc Increase Decrease In Government Relief Funds
IncreaseDecreaseInGovernmentReliefFunds
-1212000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
208178000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
225989000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
157359000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
132444000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
621000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1674000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
940000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5016000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-157678000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-135786000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
40000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
20000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
85000000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
10625000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
7969000
achc Proceeds From Payments For Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
ProceedsFromPaymentsForRepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-45904000
achc Proceeds From Payments For Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
ProceedsFromPaymentsForRepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-9868000
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
2516000
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
8008000
us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
1983000
us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
847000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
20000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
28000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35976000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-95648000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14524000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5445000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
97649000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
133813000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
112173000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
128368000
achc Number Of Facilities
NumberOfFacilities
250
CY2023Q2 achc Number Of Beds
NumberOfBeds
11000
CY2023Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
39
CY2023Q2 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
72299000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
80079000
us-gaap Net Income Loss
NetIncomeLoss
138314000
us-gaap Net Income Loss
NetIncomeLoss
140916000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91044000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89724000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90691000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89492000
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
502000
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1749000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
949000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2012000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91546000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91473000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91640000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91504000
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
15371000
CY2023Q2 achc Workers Compensation Deposits
WorkersCompensationDeposits
12000000
CY2022Q4 achc Workers Compensation Deposits
WorkersCompensationDeposits
12000000
CY2023Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
11496000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
8347000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.57
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.54
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000
CY2023Q2 achc Management Transition Costs
ManagementTransitionCosts
6175000
CY2022Q2 achc Management Transition Costs
ManagementTransitionCosts
1165000
achc Management Transition Costs
ManagementTransitionCosts
10976000
achc Management Transition Costs
ManagementTransitionCosts
2200000
CY2023Q2 us-gaap Business Exit Costs1
BusinessExitCosts1
1974000
CY2022Q2 us-gaap Business Exit Costs1
BusinessExitCosts1
688000
us-gaap Business Exit Costs1
BusinessExitCosts1
2005000
us-gaap Business Exit Costs1
BusinessExitCosts1
2646000
CY2023Q2 achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
925000
CY2022Q2 achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
2087000
achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
2564000
achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
2676000
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9074000
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3940000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
15545000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7522000
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
39487000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5767000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
26883000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
27052000
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
14062000
CY2023Q2 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
9504000
CY2022Q4 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
10158000
CY2023Q2 us-gaap Inventory Net
InventoryNet
5437000
CY2022Q4 us-gaap Inventory Net
InventoryNet
5087000
CY2023Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1879000
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2255000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
120748000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
86037000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2788671000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2608619000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
714529000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
656574000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2074142000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1952045000
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
71607000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
76041000
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
72738000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
77172000
CY2023Q2 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
1131000
CY2022Q4 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
1131000
CY2023Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
4700000
CY2020 achc Income From Provider Relief Fund
IncomeFromProviderReliefFund
32800000
CY2021Q3 achc Expected Repay Of Payroll Tax Deferrals
ExpectedRepayOfPayrollTaxDeferrals
39300000
CY2023Q2 achc Accrued Expense Current
AccruedExpenseCurrent
26833000
CY2022Q4 achc Accrued Expense Current
AccruedExpenseCurrent
26699000
CY2023Q2 achc Cost Report Payable Current
CostReportPayableCurrent
25221000
CY2022Q4 achc Cost Report Payable Current
CostReportPayableCurrent
13738000
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
17586000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
17596000
CY2023Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
12128000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
12128000
CY2023Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
10311000
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
9009000
CY2023Q2 achc Government Relief Funds Liability Current
GovernmentReliefFundsLiabilityCurrent
8975000
CY2022Q4 achc Government Relief Funds Liability Current
GovernmentReliefFundsLiabilityCurrent
8975000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4052000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6653000
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
990000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
990000
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
130000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1338000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15623000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13466000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
121849000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
110592000
CY2023Q2 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
11545000
CY2022Q4 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
12647000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
1396268000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1385791000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
23906000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
21250000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1372362000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1364541000
achc Number Of Facilities Operated By Non Wholly Owned Subsidiaries
NumberOfFacilitiesOperatedByNonWhollyOwnedSubsidiaries
8
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
88257000
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
2516000
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1793000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1983000
CY2023Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
90583000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
12700000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2637496
achc Share Based Compensation Arrangement By Share Based Payment Stock Options Granted Term
ShareBasedCompensationArrangementByShareBasedPaymentStockOptionsGrantedTerm
P10Y
achc Share Based Compensation Arrangement By Share Based Payment Award
ShareBasedCompensationArrangementByShareBasedPaymentAward
0.25
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7300000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6600000
us-gaap Share Based Compensation
ShareBasedCompensation
15000000
us-gaap Share Based Compensation
ShareBasedCompensation
14500000
us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
92300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y6M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1106069
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.07
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
334260
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
55.73
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
285577
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
40.66
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
175475
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
46.98
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
979277
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
255040
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
79.49
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
122260
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
40.79
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
74415
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
55.07
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1037642
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
54.45
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M25D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
22712000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
414762
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
42.1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M4D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
13691000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
31.19
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.041
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.37
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.39
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.253
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.23
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Trd Arr Ind Title
TrdArrIndTitle
directors or officers

Files In Submission

Name View Source Status
0000950170-23-035484-index-headers.html Edgar Link pending
0000950170-23-035484-index.html Edgar Link pending
0000950170-23-035484.txt Edgar Link pending
0000950170-23-035484-xbrl.zip Edgar Link pending
achc-20230630.htm Edgar Link pending
achc-20230630.xsd Edgar Link pending
achc-ex10_2.htm Edgar Link pending
achc-ex10_3.htm Edgar Link pending
achc-ex31_1.htm Edgar Link pending
achc-ex31_2.htm Edgar Link pending
achc-ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
achc-20230630_cal.xml Edgar Link unprocessable
achc-20230630_def.xml Edgar Link unprocessable
achc-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
achc-20230630_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
achc-20230630_lab.xml Edgar Link unprocessable